Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07279714
PHASE2
Fisetin in Mild Alzheimer's Disease
Sponsor: Sunnybrook Health Sciences Centre
View on ClinicalTrials.gov
Summary
This pilot study will evaluate the safety and tolerability of the natural health product, fisetin, in older adults with mild cognitive impairment or mild Alzheimer's disease dementia.
Official title: Fisetin Intervention Study in Mild Alzheimer's Disease
Key Details
Gender
All
Age Range
60 Years - Any
Study Type
INTERVENTIONAL
Enrollment
5
Start Date
2025-12
Completion Date
2026-11
Last Updated
2025-12-12
Healthy Volunteers
No
Conditions
Interventions
OTHER
Fisetin
Fisetin 20mg/kg/day
Locations (1)
Sunnybrook Research Institute
Toronto, Ontario, Canada